Library / regulatory-reference
Ivory Coast: Ivorian Pharmaceutical Regulation Authority (AIRP)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
The Ivorian Pharmaceutical Regulation Authority, known by its French initials AIRP, is Ivory Coast's national medicines regulator, established as an autonomous authority to take over pharmaceutical regulation from the ministry's pharmacy directorate.
Abidjan is a pharmaceutical distribution hub for francophone West Africa, and the authority's registration and licensing decisions shape supply well beyond the national market.
How products enter the market
Medicines require marketing authorization after evaluation of quality, safety and efficacy, and pharmaceutical establishments and professionals are licensed and inspected.
Post-market work includes quality surveillance and action against substandard and falsified medicines, a persistent challenge in the sub-region's informal markets.
Regional and international role
The authority's creation follows the West African trend of converting ministry pharmacy directorates into autonomous agencies, a reform pattern now visible across the region.
Given Abidjan's hub role, its import-control and anti-falsification work carries sub-regional weight.
Using this profile
The authority publishes guidance and announcements in French through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: the AIRP illustrates the hub-city regulator: a young autonomous authority whose market serves as a distribution gateway for neighboring countries.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.